These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22196477)

  • 61. Phenotyping the heterogeneity of chronic obstructive pulmonary disease.
    Barker BL; Brightling CE
    Clin Sci (Lond); 2013 Mar; 124(6):371-87. PubMed ID: 23190267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Update in Chronic Obstructive Pulmonary Disease 2016.
    Allinson JP; Wedzicha JA
    Am J Respir Crit Care Med; 2017 Aug; 196(4):414-424. PubMed ID: 28570121
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical phenotypes of COPD and their impact on quality of life: A cross-sectional study.
    Anandan J; Dwivedi DP; Govindaraj V
    Respir Med; 2023 Dec; 220():107452. PubMed ID: 37944828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy.
    Riera-Martínez L; Cànaves-Gómez L; Iglesias A; Martin-Medina A; Cosío BG
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240045
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Asthma and Comorbid Conditions-Pulmonary Comorbidity.
    Gibson PG; McDonald VM; Granchelli A; Olin JT
    J Allergy Clin Immunol Pract; 2021 Nov; 9(11):3868-3875. PubMed ID: 34492401
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Chronic obstructive pulmonary disease in the light of new guidelines -  brief summary of phenotypically oriented guidelines for nonpulmonary physicians].
    Koblížek V; Chlumský J; Zindr V; Neumannová K; Zatloukal J; Sedlák V; Kociánová J; Zatloukal J; Novotná B
    Vnitr Lek; 2013 Jun; 59(6):505-14. PubMed ID: 23808748
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Asthma COPD overlap: Insights into cellular and molecular mechanisms.
    Morissette M; Godbout K; Côté A; Boulet LP
    Mol Aspects Med; 2022 Jun; 85():101021. PubMed ID: 34521557
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care.
    Mirza S; Benzo R
    Mayo Clin Proc; 2017 Jul; 92(7):1104-1112. PubMed ID: 28688465
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Defining phenotypes in COPD: an aid to personalized healthcare.
    Segreti A; Stirpe E; Rogliani P; Cazzola M
    Mol Diagn Ther; 2014 Aug; 18(4):381-8. PubMed ID: 24781789
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort.
    Cosio BG; Soriano JB; López-Campos JL; Calle M; Soler JJ; de-Torres JP; Marín JM; Martínez C; de Lucas P; Mir I; Peces-Barba G; Feu-Collado N; Solanes I; Alfageme I;
    PLoS One; 2016; 11(9):e0160770. PubMed ID: 27684372
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The treatment of patients with broncho-pulmonary pathology and concomitant disturbances of oxalic acid metabolism].
    Shaĭlieva LO; Fedoseev GB; Zorina ML; Petrova MA; Trofimov VI; Kakliugin AP
    Klin Med (Mosk); 2013; 91(8):49-53. PubMed ID: 24437186
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Bronchial diseases and heroin use. A systematic review].
    Underner M; Perriot J; Peiffer G; Brousse G; Jaafari N
    Rev Mal Respir; 2023; 40(9-10):783-809. PubMed ID: 37925326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative Study of Systemic Inflammatory Markers in Clinical Phenotypes of Chronic Obstructive Pulmonary Disease.
    Sonar M; Jayadeva BT; Shashibhushan BL
    Tanaffos; 2023 Feb; 22(2):215-220. PubMed ID: 38628879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chronic obstructive pulmonary disease phenotypes: the future of COPD.
    Han MK; Agusti A; Calverley PM; Celli BR; Criner G; Curtis JL; Fabbri LM; Goldin JG; Jones PW; Macnee W; Make BJ; Rabe KF; Rennard SI; Sciurba FC; Silverman EK; Vestbo J; Washko GR; Wouters EF; Martinez FJ
    Am J Respir Crit Care Med; 2010 Sep; 182(5):598-604. PubMed ID: 20522794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Expert Meeting on COPD: Personalized Treatment of COPD - Wishful Thinking or Reality?].
    Lorenz J; Bals R; Ewert R; Jany B; Koczulla AR; Köhnlein T; Randerath WJ; Steinkamp G; Watz H; Welte T
    Pneumologie; 2016 Oct; 70(10):638-650. PubMed ID: 27723914
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.
    Schivo M; Albertson TE; Haczku A; Kenyon NJ; Zeki AA; Kuhn BT; Louie S; Avdalovic MV
    J Investig Med; 2017 Aug; 65(6):953-963. PubMed ID: 28258130
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study.
    Papi A; Magnoni MS; Muzzio CC; Benso G; Rizzi A
    Monaldi Arch Chest Dis; 2016 Oct; 83(1-2):721. PubMed ID: 27748465
    [TBL] [Abstract][Full Text] [Related]  

  • 78. "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".
    Corlateanu A; Mendez Y; Wang Y; Garnica RJA; Botnaru V; Siafakas N
    Pulmonology; 2020; 26(2):95-100. PubMed ID: 31740261
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gene therapy for chronic obstructive pulmonary disease: twilight or triumph?
    Al-Jamal R; Wallace WA; Harrison DJ
    Expert Opin Biol Ther; 2005 Mar; 5(3):333-46. PubMed ID: 15833071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Understanding COPD: A vision on phenotypes, comorbidities and treatment approach.
    Fragoso E; André S; Boleo-Tomé JP; Areias V; Munhá J; Cardoso J;
    Rev Port Pneumol (2006); 2016; 22(2):101-11. PubMed ID: 26827246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.